Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction
Results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) Trial
Kenneth W. Mahaffey, MD, FACCa* || ¶ #,
Joseph A. Puma, DOa* || ¶ #,
N. Alejandro Barbagelata, MD*,
Marcelo F. DiCarli, MD ,
Massoud A. Leesar, MD ,
Kevin F. Browne, MD ,
Paul R. Eisenberg, MD||,
Roberto Bolli, MD ,
A. Cecilia Casas, MSa* || ¶ #,
Victor Molina-Viamonte, MD¶,
Cesare Orlandi, MD¶,
Roger Blevins, PharmD¶,
Raymond J. Gibbons, MD, FACC#,
Robert M. Califf, MD, FACCa* || ¶ #,
Christopher B. Granger, MD, FACCa* || ¶ # for the AMISTAD Investigators
a Duke Clinical Research Institute, Durham, North Carolina, USA
* Favaloro Foundation, Buenos Aires, Argentina
Harper Hospital, Detroit, Michigan, USA
University of Louisville, Louisville, Kentucky, USA
The Watson Clinic, Lakeland, Florida, USA
|| Washington University, St. Louis, Missouri, USA
¶ Medco Research, Inc., Research Triangle Park, North Carolina, USA
# The Mayo Clinic, Rochester, Minnesota, USA

View larger version (13K):
[in a new window]
|
Figure 1 Stratification and randomization scheme showing the number of patients in each treatment arm and number of patients with determination of final infarct size.
|
|

View larger version (19K):
[in a new window]
|
Figure 2 Box-and-whisker plots of the final infarct size as a percentage of the left ventricle by treatment group and infarct location. The boxes represent the 25th and 75th interquartile ranges; vertical lines represent the 5th and 95th percentiles. The median values are shown above the horizontal lines.
|
|

View larger version (19K):
[in a new window]
|
Figure 3 Myocardial salvage index = (myocardium at risk final infarct size)/(final infarct size). See Figure 2 for description of box-and-whisker plots.
|
|
|